October 20, 2025
Seven-month extension valued at up to approximately $1.8 million CAD supports further evaluation as RDT advances broader commercialization initiatives for NicStrip™ Burlington, Ontario – October 20, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company developing innovative...
October 2, 2025
BURLINGTON, Ontario – October 1, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its private placement financing (the “Financing”), and consistent with prior quarters, the Company...
August 4, 2025
Innovative Oral Nicotine Delivery Technology Targets Safer Alternative for Smokers Burlington, ON – August 4, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug delivery technologies, is pleased to announce the submission of...
July 29, 2025
Burlington, Ontario – July 29, 2025– Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company, is proud to announce the launch of a new significant harm reduction initiative aimed at addressing the devastating opioid crisis gripping Canada’s First Nations communities....
July 22, 2025
In a recent interview with CEO.ca, Mark Upsdell, CEO of Rapid Dose Therapeutics (CSE: DOSE), discussed their game-changing QuickStrip technology that delivers medication “right into your bloodstream”. Their three-year development of nicotine strips targets the projected $20.3B non-smoking market by 2030, while also revolutionizing pain-free...
July 3, 2025
We are pleased to share that CEO.ca has issued a press release as part of its latest Inside the Boardroom series, featuring Rapid Dose Therapeutics. In June, QuickStrip™ by Rapid Dose Therapeutics was featured in RecoverCann’s WGY6 campaign for Men’s Mental Health and PTSD Awareness...
July 3, 2025
BURLINGTON, Ontario – July 2, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its private placement financing (the “Financing”), and consistent with prior quarters, the Company...
July 3, 2025
BURLINGTON, Ontario – June 27, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that it has agreed with its non-management directors (the “Directors”) to issue common shares (the “Debt Shares”) to such Directors in exchange for the cancellation of Director...
June 2, 2025
BURLINGTON, Ontario – May 30, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated May 10, 2025, it has entered into debt settlement agreements with certain of its creditors (the “Creditors”) to issue...
May 27, 2025
BURLINGTON, Ontario – May 27, 2025 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $3,000,000 of gross proceeds, consisting of up to 13,636,364 units (the...